ACMPR is an acronym for “Access to Cannabis for Medical Purposes Regulations“, also known as Canada’s medical marjuana law. The Access to Cannabis for Medical Purposes Regulations are promulgated under the Controlled Drugs and Substances Act.
The ACMPR is Canada’s response to the Federal Court of Canada’s February 2016 decision in Allard v. Canada which is a precedent setting Charter challenge of Canada’s prior medical cannabis laws.
Under the ACMPR, individuals can register with the Minister of Health to produce cannabis and this will continue under the new regulations. The application process starts with the ACMPR, Production for Own Medical Purposes and Production by a Designated Person Registration Form, which is filed with Health Canada